Review of the Onboarding Experience of a New 20% Human Immune Globulin for Subcutaneous Administration (SCIG 20%): Correlation of Infusion Parameters and Adverse Events (AEs)

Authors :: Christopher J. Rabbat
Isaac Melamed
Leman Yel
Werner Engl
Iftikhar Hussain
Mark R. Stein
Barbara McCoy
Kenneth Paris
Sudhir Gupta
Source :: Journal of Allergy and Clinical Immunology. 139:AB216
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: business.industry
Immunology
Immunology and Allergy
Medicine
Human immune globulin
Onboarding
business
Adverse effect

Tools